Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Ethnicity and Immigration Status as Risk Factors for Gestational Diabetes Mellitus, Anemia and Pregnancy Outcomes Among Food Insecure Women Attending the Montreal Diet Dispensary Program.

Ménard V, Sotunde OF, Weiler HA.

Can J Diabetes. 2019 May 17. pii: S1499-2671(18)30707-X. doi: 10.1016/j.jcjd.2019.05.004. [Epub ahead of print]

PMID:
31427254
2.

Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.

Ménard V, Lévesque E, Chen S, Eap O, Joy MS, Ekström L, Rane A, Guillemette C.

Pharmacogenet Genomics. 2013 Dec;23(12):684-96. doi: 10.1097/FPC.0000000000000008.

PMID:
24128937
3.

Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing.

Ménard V, Collin P, Margaillan G, Guillemette C.

Drug Metab Dispos. 2013 Dec;41(12):2197-205. doi: 10.1124/dmd.113.053876. Epub 2013 Oct 2.

PMID:
24088326
4.

Tm:LiYF4 planar waveguide laser at 1.9 μm.

Bolanos W, Starecki F, Benayad A, Brasse G, Ménard V, Doualan JL, Braud A, Moncorgé R, Camy P.

Opt Lett. 2012 Oct 1;37(19):4032-4. doi: 10.1364/OL.37.004032.

PMID:
23027269
5.

Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.

Li J, Menard V, Benish RL, Jurevic RJ, Guillemette C, Stoneking M, Zimmerman PA, Mehlotra RK.

Pharmacogenomics. 2012 Apr;13(5):555-70. doi: 10.2217/pgs.11.160.

6.

Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.

Ménard V, Eap O, Roberge J, Harvey M, Lévesque E, Guillemette C.

Pharmacogenet Genomics. 2011 Oct;21(10):631-41. doi: 10.1097/FPC.0b013e3283498147.

PMID:
21881541
7.

Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.

Lépine J, Audet-Walsh E, Grégoire J, Têtu B, Plante M, Ménard V, Ayotte P, Brisson J, Caron P, Villeneuve L, Bélanger A, Guillemette C.

J Clin Endocrinol Metab. 2010 Jun;95(6):2689-98. doi: 10.1210/jc.2010-2648. Epub 2010 Apr 6.

PMID:
20371658
8.

Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation.

Lévesque E, Ménard V, Laverdière I, Bellemare J, Barbier O, Girard H, Guillemette C.

Pharmacogenet Genomics. 2010 Mar;20(3):195-210. doi: 10.1097/FPC.0b013e328336ef1c.

PMID:
20139797
9.

UGT genomic diversity: beyond gene duplication.

Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V.

Drug Metab Rev. 2010 Feb;42(1):24-44. doi: 10.3109/03602530903210682. Review.

10.

Mode-locked operation of a diode-pumped femtosecond Yb:SrF2 laser.

Druon F, Papadopoulos DN, Boudeile J, Hanna M, Georges P, Benayad A, Camy P, Doualan JL, Ménard V, Moncorgé R.

Opt Lett. 2009 Aug 1;34(15):2354-6.

PMID:
19649095
11.

Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.

Ménard V, Eap O, Harvey M, Guillemette C, Lévesque E.

Hum Mutat. 2009 Sep;30(9):1310-9. doi: 10.1002/humu.21054.

PMID:
19572376
12.

Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.

Ménard V, Girard H, Harvey M, Pérusse L, Guillemette C.

Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946.

PMID:
19204906
13.

Thermal behaviour of ytterbium-doped fluorite crystals under high power pumping.

Boudeile J, Didierjean J, Camy P, Doualan JL, Benayad A, Ménard V, Moncorgé R, Druon F, Balembois F, Georges P.

Opt Express. 2008 Jul 7;16(14):10098-109.

PMID:
18607417
14.

A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3.

Caillier B, Lépine J, Tojcic J, Ménard V, Perusse L, Bélanger A, Barbier O, Guillemette C.

Pharmacogenet Genomics. 2007 Jul;17(7):481-95.

PMID:
17558304
15.

Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells.

Vermette M, Trottier V, Ménard V, Saint-Pierre L, Roy A, Fradette J.

Biomaterials. 2007 Jun;28(18):2850-60. Epub 2007 Feb 27.

PMID:
17374391
16.

Physicochemical characterization of poly(ethylene glycol)-modified anti-GAD antibodies.

Larson RS, Menard V, Jacobs H, Kim SW.

Bioconjug Chem. 2001 Nov-Dec;12(6):861-9.

PMID:
11716675
17.

Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Menard V, Jacobs H, Jun HS, Yoon JW, Kim SW.

Pharm Res. 1999 Jul;16(7):1059-66.

PMID:
10450931
18.

Supplemental Content

Loading ...
Support Center